Kite Pharma to Participate in September 2016 Investor Conferences
August 31 2016 - 4:05PM
Business Wire
Kite Pharma, Inc., (Nasdaq:KITE) today announced that management
will participate in a panel at the 11th Annual Citi Biotech
Conference and a fireside chat discussion at the Morgan Stanley
Global Healthcare Conference.
• 11th Annual Citi
Biotech Conference
o Date: Wednesday, September 7, 2016
o Time: 2:00 PM Eastern Time
o Location: Boston, MA
• Morgan Stanley Global Healthcare
Conference
o Date: Tuesday, September 13, 2016
o Time: 1:30 PM Eastern Time
o Location: New York, NY
A live audio webcast of each event will be available on the
Investors section of Kite’s website, www.kitepharma.com. A replay
of each webcast will be available on the website for approximately
30 days.
About Kite Pharma
Kite Pharma, Inc. is a clinical-stage biopharmaceutical
company engaged in the development of novel cancer immunotherapy
products, with a primary focus on engineered autologous cell
therapy (eACT™) designed to restore the immune system's ability to
recognize and eradicate tumors. Kite is based in Santa Monica,
CA. For more information on Kite Pharma, please
visit www.kitepharma.com. Sign up to follow @KitePharma on
Twitter at www.twitter.com/kitepharma.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160831006261/en/
Kite PharmaGreg MannVP, Investor
Relationsgmann@kitepharma.comorFor Media:inVentiv HealthDavid Polk,
310-309-1029david.polk@inventivhealth.com
KITE PHARMA, INC. (NASDAQ:KITE)
Historical Stock Chart
From Mar 2024 to Apr 2024
KITE PHARMA, INC. (NASDAQ:KITE)
Historical Stock Chart
From Apr 2023 to Apr 2024